Stephen F. Page Trust reports 1,250-share sales (AVAV)
Stephen F. Page Living Trust reported proposed and completed sales of Common stock under a 10b5-1 plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Stephen F. Page Living Trust reported proposed and completed sales of Common stock under a 10b5-1 plan. The trust recorded sales totaling 1,250 shares: 500 on 02/17/2026, 250 on 02/19/2026, 250 on 03/02/2026, and 250 on 03/16/2026. The record also shows 750 Restricted Stock Units dated 07/11/2023.
Key Figures
Key Terms
10b5-1 regulatory
Restricted Stock Units financial
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the Form 144 for AVAV disclose?
Who executed the sales reported on the AVAV Form 144?
Does the filing show proceeds from the sales for AVAV?
Are the Restricted Stock Units (RSUs) included in the AVAV filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.